PROCEEDINGS VOLUME 3259
BIOS '98 INTERNATIONAL BIOMEDICAL OPTICS SYMPOSIUM | 27-29 JANUARY 1998
Systems and Technologies for Clinical Diagnostics and Drug Discovery
BIOS '98 INTERNATIONAL BIOMEDICAL OPTICS SYMPOSIUM
27-29 January 1998
San Jose, CA, United States
Multispectral Imaging in Clinical Diagnostics
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 2 (10 April 1998); doi: 10.1117/12.307320
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 11 (10 April 1998); doi: 10.1117/12.307327
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 18 (10 April 1998); doi: 10.1117/12.307335
Fluorescence-based Diagnostics
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 28 (10 April 1998); doi: 10.1117/12.307336
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 40 (10 April 1998); doi: 10.1117/12.307337
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 48 (10 April 1998); doi: 10.1117/12.307338
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 65 (10 April 1998); doi: 10.1117/12.307339
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 69 (10 April 1998); doi: 10.1117/12.307340
Ultrasensitive Clinical Diagnostic Systems
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 80 (10 April 1998); doi: 10.1117/12.307314
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 94 (10 April 1998); doi: 10.1117/12.307315
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 104 (10 April 1998); doi: 10.1117/12.307316
Cell and Tissue Diagnostics
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 114 (10 April 1998); doi: 10.1117/12.307317
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 122 (10 April 1998); doi: 10.1117/12.307318
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 130 (10 April 1998); doi: 10.1117/12.307319
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 144 (10 April 1998); doi: 10.1117/12.307321
Fluorescence-based Diagnostics
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 54 (10 April 1998); doi: 10.1117/12.307322
Fluorometric Analysis of DNA and Proteins
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 156 (10 April 1998); doi: 10.1117/12.307323
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 165 (10 April 1998); doi: 10.1117/12.307324
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 173 (10 April 1998); doi: 10.1117/12.307325
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 179 (10 April 1998); doi: 10.1117/12.307326
Optical Methods in High-Throughput Screening for Drug Discovery
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 188 (10 April 1998); doi: 10.1117/12.307328
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 197 (10 April 1998); doi: 10.1117/12.307329
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 209 (10 April 1998); doi: 10.1117/12.307330
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 219 (10 April 1998); doi: 10.1117/12.307331
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 228 (10 April 1998); doi: 10.1117/12.307332
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 234 (10 April 1998); doi: 10.1117/12.307333
Cell and Tissue Diagnostics
Proc. SPIE 3259, Systems and Technologies for Clinical Diagnostics and Drug Discovery, pg 136 (10 April 1998); doi: 10.1117/12.307334
Back to Top